nodes	percent_of_prediction	percent_of_DWPC	metapath
Nizatidine—ABCB1—Ezetimibe—atherosclerosis	0.136	0.267	CbGbCtD
Nizatidine—ABCB1—Simvastatin—atherosclerosis	0.126	0.248	CbGbCtD
Nizatidine—ABCB1—Lovastatin—atherosclerosis	0.124	0.243	CbGbCtD
Nizatidine—ABCB1—Pravastatin—atherosclerosis	0.124	0.243	CbGbCtD
Nizatidine—Laryngeal oedema—Niacin—atherosclerosis	0.00525	0.0153	CcSEcCtD
Nizatidine—Hepatic enzyme increased—Rosuvastatin—atherosclerosis	0.00489	0.0142	CcSEcCtD
Nizatidine—Amblyopia—Niacin—atherosclerosis	0.00436	0.0127	CcSEcCtD
Nizatidine—Gynaecomastia—Rosuvastatin—atherosclerosis	0.00414	0.012	CcSEcCtD
Nizatidine—Vasculitis—Lovastatin—atherosclerosis	0.00402	0.0117	CcSEcCtD
Nizatidine—Vasculitis—Ezetimibe—atherosclerosis	0.00394	0.0115	CcSEcCtD
Nizatidine—Hepatocellular injury—Ezetimibe—atherosclerosis	0.00385	0.0112	CcSEcCtD
Nizatidine—Vasculitis—Simvastatin—atherosclerosis	0.00376	0.0109	CcSEcCtD
Nizatidine—Hepatocellular injury—Simvastatin—atherosclerosis	0.00367	0.0107	CcSEcCtD
Nizatidine—Hyperuricaemia—Niacin—atherosclerosis	0.00363	0.0106	CcSEcCtD
Nizatidine—Gout—Niacin—atherosclerosis	0.00361	0.0105	CcSEcCtD
Nizatidine—Gynaecomastia—Lovastatin—atherosclerosis	0.00351	0.0102	CcSEcCtD
Nizatidine—Blood uric acid increased—Niacin—atherosclerosis	0.00343	0.00997	CcSEcCtD
Nizatidine—Vasculitis—Pravastatin—atherosclerosis	0.0034	0.00988	CcSEcCtD
Nizatidine—Hepatocellular injury—Pravastatin—atherosclerosis	0.00332	0.00964	CcSEcCtD
Nizatidine—Gynaecomastia—Simvastatin—atherosclerosis	0.00328	0.00954	CcSEcCtD
Nizatidine—Gynaecomastia—Pravastatin—atherosclerosis	0.00297	0.00863	CcSEcCtD
Nizatidine—Jaundice—Rosuvastatin—atherosclerosis	0.00252	0.00734	CcSEcCtD
Nizatidine—Nasopharyngitis—Ezetimibe—atherosclerosis	0.0025	0.00726	CcSEcCtD
Nizatidine—Eosinophilia—Lovastatin—atherosclerosis	0.00244	0.00708	CcSEcCtD
Nizatidine—Sinusitis—Rosuvastatin—atherosclerosis	0.00243	0.00706	CcSEcCtD
Nizatidine—Disturbance in sexual arousal—Niacin—atherosclerosis	0.00243	0.00705	CcSEcCtD
Nizatidine—Eosinophilia—Ezetimibe—atherosclerosis	0.00239	0.00695	CcSEcCtD
Nizatidine—Rhinitis—Rosuvastatin—atherosclerosis	0.00233	0.00677	CcSEcCtD
Nizatidine—Hepatitis—Rosuvastatin—atherosclerosis	0.00232	0.00676	CcSEcCtD
Nizatidine—Pharyngitis—Rosuvastatin—atherosclerosis	0.00231	0.00671	CcSEcCtD
Nizatidine—Eosinophilia—Simvastatin—atherosclerosis	0.00228	0.00662	CcSEcCtD
Nizatidine—Erectile dysfunction—Lovastatin—atherosclerosis	0.00227	0.00659	CcSEcCtD
Nizatidine—Erectile dysfunction—Ezetimibe—atherosclerosis	0.00222	0.00646	CcSEcCtD
Nizatidine—Nasopharyngitis—Pravastatin—atherosclerosis	0.00215	0.00626	CcSEcCtD
Nizatidine—Erectile dysfunction—Simvastatin—atherosclerosis	0.00212	0.00616	CcSEcCtD
Nizatidine—Jaundice—Ezetimibe—atherosclerosis	0.0021	0.0061	CcSEcCtD
Nizatidine—Eosinophilia—Pravastatin—atherosclerosis	0.00206	0.00599	CcSEcCtD
Nizatidine—Sinusitis—Lovastatin—atherosclerosis	0.00206	0.00598	CcSEcCtD
Nizatidine—Sinusitis—Ezetimibe—atherosclerosis	0.00202	0.00587	CcSEcCtD
Nizatidine—Jaundice—Simvastatin—atherosclerosis	0.002	0.00582	CcSEcCtD
Nizatidine—Flatulence—Rosuvastatin—atherosclerosis	0.00199	0.0058	CcSEcCtD
Nizatidine—Hepatitis—Lovastatin—atherosclerosis	0.00197	0.00573	CcSEcCtD
Nizatidine—Erectile dysfunction—Niacin—atherosclerosis	0.00195	0.00566	CcSEcCtD
Nizatidine—Hepatitis—Ezetimibe—atherosclerosis	0.00193	0.00562	CcSEcCtD
Nizatidine—Sinusitis—Simvastatin—atherosclerosis	0.00192	0.0056	CcSEcCtD
Nizatidine—Pharyngitis—Ezetimibe—atherosclerosis	0.00192	0.00557	CcSEcCtD
Nizatidine—Erectile dysfunction—Pravastatin—atherosclerosis	0.00192	0.00557	CcSEcCtD
Nizatidine—Hepatitis—Simvastatin—atherosclerosis	0.00184	0.00536	CcSEcCtD
Nizatidine—Jaundice—Niacin—atherosclerosis	0.00184	0.00534	CcSEcCtD
Nizatidine—Jaundice—Pravastatin—atherosclerosis	0.00181	0.00526	CcSEcCtD
Nizatidine—Sweating—Niacin—atherosclerosis	0.00181	0.00525	CcSEcCtD
Nizatidine—Cough—Rosuvastatin—atherosclerosis	0.00177	0.00513	CcSEcCtD
Nizatidine—Sinusitis—Pravastatin—atherosclerosis	0.00174	0.00506	CcSEcCtD
Nizatidine—Myalgia—Rosuvastatin—atherosclerosis	0.00172	0.00501	CcSEcCtD
Nizatidine—Rhinitis—Niacin—atherosclerosis	0.0017	0.00493	CcSEcCtD
Nizatidine—Hepatitis—Niacin—atherosclerosis	0.00169	0.00492	CcSEcCtD
Nizatidine—Flatulence—Lovastatin—atherosclerosis	0.00169	0.00491	CcSEcCtD
Nizatidine—Rhinitis—Pravastatin—atherosclerosis	0.00167	0.00485	CcSEcCtD
Nizatidine—Hepatitis—Pravastatin—atherosclerosis	0.00167	0.00484	CcSEcCtD
Nizatidine—Confusional state—Rosuvastatin—atherosclerosis	0.00166	0.00484	CcSEcCtD
Nizatidine—Back pain—Lovastatin—atherosclerosis	0.00166	0.00482	CcSEcCtD
Nizatidine—Flatulence—Ezetimibe—atherosclerosis	0.00166	0.00482	CcSEcCtD
Nizatidine—Pharyngitis—Pravastatin—atherosclerosis	0.00165	0.00481	CcSEcCtD
Nizatidine—Infection—Rosuvastatin—atherosclerosis	0.00164	0.00477	CcSEcCtD
Nizatidine—Back pain—Ezetimibe—atherosclerosis	0.00163	0.00473	CcSEcCtD
Nizatidine—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.00162	0.0047	CcSEcCtD
Nizatidine—Flatulence—Simvastatin—atherosclerosis	0.00158	0.00459	CcSEcCtD
Nizatidine—Anaemia—Ezetimibe—atherosclerosis	0.00155	0.00452	CcSEcCtD
Nizatidine—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.0015	0.00437	CcSEcCtD
Nizatidine—Insomnia—Rosuvastatin—atherosclerosis	0.00149	0.00434	CcSEcCtD
Nizatidine—Anaemia—Simvastatin—atherosclerosis	0.00148	0.00431	CcSEcCtD
Nizatidine—Cough—Ezetimibe—atherosclerosis	0.00147	0.00427	CcSEcCtD
Nizatidine—Myalgia—Lovastatin—atherosclerosis	0.00146	0.00424	CcSEcCtD
Nizatidine—Chest pain—Lovastatin—atherosclerosis	0.00146	0.00424	CcSEcCtD
Nizatidine—Anxiety—Lovastatin—atherosclerosis	0.00145	0.00423	CcSEcCtD
Nizatidine—Dyspepsia—Rosuvastatin—atherosclerosis	0.00145	0.00423	CcSEcCtD
Nizatidine—Flatulence—Niacin—atherosclerosis	0.00145	0.00422	CcSEcCtD
Nizatidine—Tension—Niacin—atherosclerosis	0.00144	0.0042	CcSEcCtD
Nizatidine—Chest pain—Ezetimibe—atherosclerosis	0.00143	0.00416	CcSEcCtD
Nizatidine—Myalgia—Ezetimibe—atherosclerosis	0.00143	0.00416	CcSEcCtD
Nizatidine—Nervousness—Niacin—atherosclerosis	0.00143	0.00416	CcSEcCtD
Nizatidine—Flatulence—Pravastatin—atherosclerosis	0.00143	0.00415	CcSEcCtD
Nizatidine—Dry mouth—Lovastatin—atherosclerosis	0.00143	0.00415	CcSEcCtD
Nizatidine—Tension—Pravastatin—atherosclerosis	0.00142	0.00414	CcSEcCtD
Nizatidine—Constipation—Rosuvastatin—atherosclerosis	0.00141	0.0041	CcSEcCtD
Nizatidine—Pain—Rosuvastatin—atherosclerosis	0.00141	0.0041	CcSEcCtD
Nizatidine—Confusional state—Lovastatin—atherosclerosis	0.00141	0.0041	CcSEcCtD
Nizatidine—Nervousness—Pravastatin—atherosclerosis	0.00141	0.00409	CcSEcCtD
Nizatidine—Dry mouth—Ezetimibe—atherosclerosis	0.0014	0.00407	CcSEcCtD
Nizatidine—Anaphylactic shock—Lovastatin—atherosclerosis	0.0014	0.00407	CcSEcCtD
Nizatidine—Infection—Lovastatin—atherosclerosis	0.00139	0.00404	CcSEcCtD
Nizatidine—Confusional state—Ezetimibe—atherosclerosis	0.00138	0.00402	CcSEcCtD
Nizatidine—Anaphylactic shock—Ezetimibe—atherosclerosis	0.00137	0.00399	CcSEcCtD
Nizatidine—Thrombocytopenia—Lovastatin—atherosclerosis	0.00137	0.00398	CcSEcCtD
Nizatidine—Chest pain—Simvastatin—atherosclerosis	0.00137	0.00397	CcSEcCtD
Nizatidine—Myalgia—Simvastatin—atherosclerosis	0.00137	0.00397	CcSEcCtD
Nizatidine—Infection—Ezetimibe—atherosclerosis	0.00136	0.00396	CcSEcCtD
Nizatidine—Feeling abnormal—Rosuvastatin—atherosclerosis	0.00136	0.00396	CcSEcCtD
Nizatidine—Anxiety—Simvastatin—atherosclerosis	0.00136	0.00396	CcSEcCtD
Nizatidine—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.00135	0.00393	CcSEcCtD
Nizatidine—Thrombocytopenia—Ezetimibe—atherosclerosis	0.00134	0.00391	CcSEcCtD
Nizatidine—Anaemia—Pravastatin—atherosclerosis	0.00134	0.0039	CcSEcCtD
Nizatidine—Anorexia—Lovastatin—atherosclerosis	0.00133	0.00388	CcSEcCtD
Nizatidine—Confusional state—Simvastatin—atherosclerosis	0.00132	0.00384	CcSEcCtD
Nizatidine—Urticaria—Rosuvastatin—atherosclerosis	0.00131	0.00381	CcSEcCtD
Nizatidine—Anaphylactic shock—Simvastatin—atherosclerosis	0.00131	0.0038	CcSEcCtD
Nizatidine—Abdominal pain—Rosuvastatin—atherosclerosis	0.00131	0.00379	CcSEcCtD
Nizatidine—Infection—Simvastatin—atherosclerosis	0.0013	0.00378	CcSEcCtD
Nizatidine—Cough—Niacin—atherosclerosis	0.00128	0.00374	CcSEcCtD
Nizatidine—Thrombocytopenia—Simvastatin—atherosclerosis	0.00128	0.00373	CcSEcCtD
Nizatidine—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.00127	0.00371	CcSEcCtD
Nizatidine—Insomnia—Lovastatin—atherosclerosis	0.00127	0.00368	CcSEcCtD
Nizatidine—Cough—Pravastatin—atherosclerosis	0.00126	0.00368	CcSEcCtD
Nizatidine—Myalgia—Niacin—atherosclerosis	0.00125	0.00364	CcSEcCtD
Nizatidine—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.00125	0.00364	CcSEcCtD
Nizatidine—Anorexia—Simvastatin—atherosclerosis	0.00125	0.00363	CcSEcCtD
Nizatidine—Insomnia—Ezetimibe—atherosclerosis	0.00124	0.00361	CcSEcCtD
Nizatidine—Chest pain—Pravastatin—atherosclerosis	0.00123	0.00359	CcSEcCtD
Nizatidine—Myalgia—Pravastatin—atherosclerosis	0.00123	0.00359	CcSEcCtD
Nizatidine—Dyspepsia—Lovastatin—atherosclerosis	0.00123	0.00358	CcSEcCtD
Nizatidine—Anxiety—Pravastatin—atherosclerosis	0.00123	0.00358	CcSEcCtD
Nizatidine—Dry mouth—Niacin—atherosclerosis	0.00123	0.00356	CcSEcCtD
Nizatidine—Decreased appetite—Lovastatin—atherosclerosis	0.00122	0.00354	CcSEcCtD
Nizatidine—Dyspepsia—Ezetimibe—atherosclerosis	0.00121	0.00351	CcSEcCtD
Nizatidine—Anaphylactic shock—Niacin—atherosclerosis	0.0012	0.00349	CcSEcCtD
Nizatidine—Pain—Lovastatin—atherosclerosis	0.0012	0.00348	CcSEcCtD
Nizatidine—Constipation—Lovastatin—atherosclerosis	0.0012	0.00348	CcSEcCtD
Nizatidine—Confusional state—Pravastatin—atherosclerosis	0.00119	0.00347	CcSEcCtD
Nizatidine—Decreased appetite—Ezetimibe—atherosclerosis	0.00119	0.00347	CcSEcCtD
Nizatidine—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.00119	0.00347	CcSEcCtD
Nizatidine—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.00118	0.00344	CcSEcCtD
Nizatidine—Asthenia—Rosuvastatin—atherosclerosis	0.00118	0.00344	CcSEcCtD
Nizatidine—Insomnia—Simvastatin—atherosclerosis	0.00118	0.00344	CcSEcCtD
Nizatidine—Anaphylactic shock—Pravastatin—atherosclerosis	0.00118	0.00344	CcSEcCtD
Nizatidine—Infection—Pravastatin—atherosclerosis	0.00118	0.00342	CcSEcCtD
Nizatidine—Pain—Ezetimibe—atherosclerosis	0.00117	0.00341	CcSEcCtD
Nizatidine—Constipation—Ezetimibe—atherosclerosis	0.00117	0.00341	CcSEcCtD
Nizatidine—Pruritus—Rosuvastatin—atherosclerosis	0.00117	0.0034	CcSEcCtD
Nizatidine—Hyperhidrosis—Niacin—atherosclerosis	0.00116	0.00338	CcSEcCtD
Nizatidine—Thrombocytopenia—Pravastatin—atherosclerosis	0.00116	0.00337	CcSEcCtD
Nizatidine—Feeling abnormal—Lovastatin—atherosclerosis	0.00115	0.00335	CcSEcCtD
Nizatidine—Dyspepsia—Simvastatin—atherosclerosis	0.00115	0.00335	CcSEcCtD
Nizatidine—Anorexia—Niacin—atherosclerosis	0.00115	0.00333	CcSEcCtD
Nizatidine—Gastrointestinal pain—Lovastatin—atherosclerosis	0.00114	0.00333	CcSEcCtD
Nizatidine—Hyperhidrosis—Pravastatin—atherosclerosis	0.00114	0.00333	CcSEcCtD
Nizatidine—Decreased appetite—Simvastatin—atherosclerosis	0.00114	0.00331	CcSEcCtD
Nizatidine—Feeling abnormal—Ezetimibe—atherosclerosis	0.00113	0.00329	CcSEcCtD
Nizatidine—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.00113	0.00328	CcSEcCtD
Nizatidine—Diarrhoea—Rosuvastatin—atherosclerosis	0.00113	0.00328	CcSEcCtD
Nizatidine—Anorexia—Pravastatin—atherosclerosis	0.00113	0.00328	CcSEcCtD
Nizatidine—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.00112	0.00326	CcSEcCtD
Nizatidine—Pain—Simvastatin—atherosclerosis	0.00112	0.00325	CcSEcCtD
Nizatidine—Constipation—Simvastatin—atherosclerosis	0.00112	0.00325	CcSEcCtD
Nizatidine—Urticaria—Lovastatin—atherosclerosis	0.00111	0.00323	CcSEcCtD
Nizatidine—Abdominal pain—Lovastatin—atherosclerosis	0.00111	0.00322	CcSEcCtD
Nizatidine—Body temperature increased—Lovastatin—atherosclerosis	0.00111	0.00322	CcSEcCtD
Nizatidine—Musculoskeletal discomfort—Niacin—atherosclerosis	0.00109	0.00318	CcSEcCtD
Nizatidine—Dizziness—Rosuvastatin—atherosclerosis	0.00109	0.00317	CcSEcCtD
Nizatidine—Urticaria—Ezetimibe—atherosclerosis	0.00109	0.00317	CcSEcCtD
Nizatidine—Insomnia—Niacin—atherosclerosis	0.00109	0.00316	CcSEcCtD
Nizatidine—Abdominal pain—Ezetimibe—atherosclerosis	0.00108	0.00315	CcSEcCtD
Nizatidine—Body temperature increased—Ezetimibe—atherosclerosis	0.00108	0.00315	CcSEcCtD
Nizatidine—Feeling abnormal—Simvastatin—atherosclerosis	0.00108	0.00314	CcSEcCtD
Nizatidine—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.00108	0.00313	CcSEcCtD
Nizatidine—Gastrointestinal pain—Simvastatin—atherosclerosis	0.00107	0.00311	CcSEcCtD
Nizatidine—Insomnia—Pravastatin—atherosclerosis	0.00107	0.00311	CcSEcCtD
Nizatidine—Somnolence—Niacin—atherosclerosis	0.00107	0.00311	CcSEcCtD
Nizatidine—Dyspepsia—Niacin—atherosclerosis	0.00106	0.00308	CcSEcCtD
Nizatidine—Decreased appetite—Niacin—atherosclerosis	0.00104	0.00304	CcSEcCtD
Nizatidine—Dyspepsia—Pravastatin—atherosclerosis	0.00104	0.00303	CcSEcCtD
Nizatidine—Rash—Rosuvastatin—atherosclerosis	0.00104	0.00303	CcSEcCtD
Nizatidine—Dermatitis—Rosuvastatin—atherosclerosis	0.00104	0.00302	CcSEcCtD
Nizatidine—Urticaria—Simvastatin—atherosclerosis	0.00104	0.00302	CcSEcCtD
Nizatidine—Gastrointestinal disorder—Niacin—atherosclerosis	0.00104	0.00302	CcSEcCtD
Nizatidine—Body temperature increased—Simvastatin—atherosclerosis	0.00103	0.00301	CcSEcCtD
Nizatidine—Abdominal pain—Simvastatin—atherosclerosis	0.00103	0.00301	CcSEcCtD
Nizatidine—Headache—Rosuvastatin—atherosclerosis	0.00103	0.00301	CcSEcCtD
Nizatidine—Decreased appetite—Pravastatin—atherosclerosis	0.00103	0.00299	CcSEcCtD
Nizatidine—Pain—Niacin—atherosclerosis	0.00103	0.00299	CcSEcCtD
Nizatidine—Constipation—Pravastatin—atherosclerosis	0.00101	0.00294	CcSEcCtD
Nizatidine—Pain—Pravastatin—atherosclerosis	0.00101	0.00294	CcSEcCtD
Nizatidine—Asthenia—Lovastatin—atherosclerosis	0.001	0.00292	CcSEcCtD
Nizatidine—Pruritus—Lovastatin—atherosclerosis	0.00099	0.00288	CcSEcCtD
Nizatidine—Asthenia—Ezetimibe—atherosclerosis	0.000985	0.00286	CcSEcCtD
Nizatidine—Gastrointestinal pain—Niacin—atherosclerosis	0.000983	0.00286	CcSEcCtD
Nizatidine—Nausea—Rosuvastatin—atherosclerosis	0.000981	0.00285	CcSEcCtD
Nizatidine—Feeling abnormal—Pravastatin—atherosclerosis	0.000975	0.00283	CcSEcCtD
Nizatidine—Pruritus—Ezetimibe—atherosclerosis	0.000971	0.00282	CcSEcCtD
Nizatidine—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000967	0.00281	CcSEcCtD
Nizatidine—Diarrhoea—Lovastatin—atherosclerosis	0.000957	0.00278	CcSEcCtD
Nizatidine—Urticaria—Niacin—atherosclerosis	0.000955	0.00278	CcSEcCtD
Nizatidine—Abdominal pain—Niacin—atherosclerosis	0.00095	0.00276	CcSEcCtD
Nizatidine—Body temperature increased—Niacin—atherosclerosis	0.00095	0.00276	CcSEcCtD
Nizatidine—Urticaria—Pravastatin—atherosclerosis	0.00094	0.00273	CcSEcCtD
Nizatidine—Asthenia—Simvastatin—atherosclerosis	0.000939	0.00273	CcSEcCtD
Nizatidine—Diarrhoea—Ezetimibe—atherosclerosis	0.000939	0.00273	CcSEcCtD
Nizatidine—Abdominal pain—Pravastatin—atherosclerosis	0.000935	0.00272	CcSEcCtD
Nizatidine—Body temperature increased—Pravastatin—atherosclerosis	0.000935	0.00272	CcSEcCtD
Nizatidine—Pruritus—Simvastatin—atherosclerosis	0.000926	0.00269	CcSEcCtD
Nizatidine—Dizziness—Lovastatin—atherosclerosis	0.000925	0.00269	CcSEcCtD
Nizatidine—Dizziness—Ezetimibe—atherosclerosis	0.000907	0.00264	CcSEcCtD
Nizatidine—Diarrhoea—Simvastatin—atherosclerosis	0.000895	0.0026	CcSEcCtD
Nizatidine—Vomiting—Lovastatin—atherosclerosis	0.00089	0.00259	CcSEcCtD
Nizatidine—Rash—Lovastatin—atherosclerosis	0.000882	0.00256	CcSEcCtD
Nizatidine—Dermatitis—Lovastatin—atherosclerosis	0.000881	0.00256	CcSEcCtD
Nizatidine—Headache—Lovastatin—atherosclerosis	0.000876	0.00255	CcSEcCtD
Nizatidine—Vomiting—Ezetimibe—atherosclerosis	0.000872	0.00254	CcSEcCtD
Nizatidine—Dizziness—Simvastatin—atherosclerosis	0.000865	0.00252	CcSEcCtD
Nizatidine—Rash—Ezetimibe—atherosclerosis	0.000865	0.00252	CcSEcCtD
Nizatidine—Dermatitis—Ezetimibe—atherosclerosis	0.000864	0.00251	CcSEcCtD
Nizatidine—Asthenia—Niacin—atherosclerosis	0.000862	0.00251	CcSEcCtD
Nizatidine—Headache—Ezetimibe—atherosclerosis	0.00086	0.0025	CcSEcCtD
Nizatidine—Pruritus—Niacin—atherosclerosis	0.00085	0.00247	CcSEcCtD
Nizatidine—Asthenia—Pravastatin—atherosclerosis	0.000849	0.00247	CcSEcCtD
Nizatidine—Pruritus—Pravastatin—atherosclerosis	0.000837	0.00243	CcSEcCtD
Nizatidine—Vomiting—Simvastatin—atherosclerosis	0.000832	0.00242	CcSEcCtD
Nizatidine—Nausea—Lovastatin—atherosclerosis	0.000831	0.00242	CcSEcCtD
Nizatidine—Rash—Simvastatin—atherosclerosis	0.000825	0.0024	CcSEcCtD
Nizatidine—Dermatitis—Simvastatin—atherosclerosis	0.000824	0.0024	CcSEcCtD
Nizatidine—Diarrhoea—Niacin—atherosclerosis	0.000822	0.00239	CcSEcCtD
Nizatidine—Headache—Simvastatin—atherosclerosis	0.00082	0.00238	CcSEcCtD
Nizatidine—Nausea—Ezetimibe—atherosclerosis	0.000815	0.00237	CcSEcCtD
Nizatidine—Diarrhoea—Pravastatin—atherosclerosis	0.000809	0.00235	CcSEcCtD
Nizatidine—Dizziness—Niacin—atherosclerosis	0.000795	0.00231	CcSEcCtD
Nizatidine—Dizziness—Pravastatin—atherosclerosis	0.000782	0.00227	CcSEcCtD
Nizatidine—Nausea—Simvastatin—atherosclerosis	0.000777	0.00226	CcSEcCtD
Nizatidine—Vomiting—Niacin—atherosclerosis	0.000764	0.00222	CcSEcCtD
Nizatidine—Rash—Niacin—atherosclerosis	0.000758	0.0022	CcSEcCtD
Nizatidine—Dermatitis—Niacin—atherosclerosis	0.000757	0.0022	CcSEcCtD
Nizatidine—Headache—Niacin—atherosclerosis	0.000753	0.00219	CcSEcCtD
Nizatidine—Vomiting—Pravastatin—atherosclerosis	0.000752	0.00219	CcSEcCtD
Nizatidine—Rash—Pravastatin—atherosclerosis	0.000746	0.00217	CcSEcCtD
Nizatidine—Dermatitis—Pravastatin—atherosclerosis	0.000745	0.00217	CcSEcCtD
Nizatidine—Headache—Pravastatin—atherosclerosis	0.000741	0.00216	CcSEcCtD
Nizatidine—Nausea—Niacin—atherosclerosis	0.000714	0.00208	CcSEcCtD
Nizatidine—Nausea—Pravastatin—atherosclerosis	0.000703	0.00204	CcSEcCtD
Nizatidine—BCHE—Metabolism of lipids and lipoproteins—APOC3—atherosclerosis	0.000192	0.00131	CbGpPWpGaD
Nizatidine—BCHE—Metabolism of lipids and lipoproteins—LDLR—atherosclerosis	0.000191	0.0013	CbGpPWpGaD
Nizatidine—ABCB1—Transmembrane transport of small molecules—ABCG8—atherosclerosis	0.000189	0.00129	CbGpPWpGaD
Nizatidine—BCHE—Metabolism of lipids and lipoproteins—CETP—atherosclerosis	0.000187	0.00127	CbGpPWpGaD
Nizatidine—HRH2—Signaling by GPCR—CCL3—atherosclerosis	0.000186	0.00127	CbGpPWpGaD
Nizatidine—HRH2—GPCR downstream signaling—EDNRA—atherosclerosis	0.000185	0.00126	CbGpPWpGaD
Nizatidine—HRH2—GPCR downstream signaling—CCR2—atherosclerosis	0.000185	0.00126	CbGpPWpGaD
Nizatidine—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—atherosclerosis	0.000182	0.00124	CbGpPWpGaD
Nizatidine—HRH2—GPCR ligand binding—F2—atherosclerosis	0.000181	0.00124	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—ABCG8—atherosclerosis	0.000181	0.00123	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—LTA4H—atherosclerosis	0.000181	0.00123	CbGpPWpGaD
Nizatidine—HRH2—GPCR downstream signaling—GHRL—atherosclerosis	0.000181	0.00123	CbGpPWpGaD
Nizatidine—BCHE—Metabolism of lipids and lipoproteins—SCARB1—atherosclerosis	0.000179	0.00122	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—APOA4—atherosclerosis	0.000175	0.00119	CbGpPWpGaD
Nizatidine—BCHE—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	0.000169	0.00115	CbGpPWpGaD
Nizatidine—HRH2—Signaling by GPCR—EDNRA—atherosclerosis	0.000168	0.00115	CbGpPWpGaD
Nizatidine—HRH2—Signaling by GPCR—CCR2—atherosclerosis	0.000168	0.00115	CbGpPWpGaD
Nizatidine—HRH2—Class A/1 (Rhodopsin-like receptors)—CXCL8—atherosclerosis	0.000168	0.00114	CbGpPWpGaD
Nizatidine—ABCB1—Allograft Rejection—IFNG—atherosclerosis	0.000167	0.00114	CbGpPWpGaD
Nizatidine—HRH2—Signaling by GPCR—GHRL—atherosclerosis	0.000164	0.00112	CbGpPWpGaD
Nizatidine—HRH2—GPCR ligand binding—CCL2—atherosclerosis	0.000162	0.0011	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—CCL4—atherosclerosis	0.000161	0.0011	CbGpPWpGaD
Nizatidine—BCHE—Metabolism of proteins—F7—atherosclerosis	0.000159	0.00109	CbGpPWpGaD
Nizatidine—HRH2—GPCR downstream signaling—KNG1—atherosclerosis	0.000159	0.00108	CbGpPWpGaD
Nizatidine—HRH2—GPCR downstream signaling—AGTR1—atherosclerosis	0.000158	0.00107	CbGpPWpGaD
Nizatidine—ABCB1—Allograft Rejection—CXCL8—atherosclerosis	0.000156	0.00106	CbGpPWpGaD
Nizatidine—BCHE—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	0.00015	0.00103	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—APOA2—atherosclerosis	0.00015	0.00102	CbGpPWpGaD
Nizatidine—ABCB1—Allograft Rejection—IL1B—atherosclerosis	0.000149	0.00102	CbGpPWpGaD
Nizatidine—ABCB1—Transmembrane transport of small molecules—ABCG1—atherosclerosis	0.000149	0.00102	CbGpPWpGaD
Nizatidine—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—atherosclerosis	0.000147	0.000999	CbGpPWpGaD
Nizatidine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—atherosclerosis	0.000146	0.000995	CbGpPWpGaD
Nizatidine—HRH2—Signaling by GPCR—KNG1—atherosclerosis	0.000144	0.000981	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—UTS2—atherosclerosis	0.000143	0.000978	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—ABCG1—atherosclerosis	0.000143	0.000976	CbGpPWpGaD
Nizatidine—HRH2—Signaling by GPCR—AGTR1—atherosclerosis	0.000143	0.000975	CbGpPWpGaD
Nizatidine—BCHE—Metabolism of proteins—GHRL—atherosclerosis	0.000142	0.000969	CbGpPWpGaD
Nizatidine—BCHE—Metabolism of proteins—ACE—atherosclerosis	0.000138	0.000938	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—CX3CR1—atherosclerosis	0.000137	0.000937	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—CASR—atherosclerosis	0.000137	0.000937	CbGpPWpGaD
Nizatidine—ABCB1—Transmembrane transport of small molecules—CYP7A1—atherosclerosis	0.000135	0.000921	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—CX3CL1—atherosclerosis	0.000135	0.000919	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—FABP4—atherosclerosis	0.000135	0.000917	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—LCAT—atherosclerosis	0.000135	0.000917	CbGpPWpGaD
Nizatidine—HRH2—GPCR downstream signaling—EDN1—atherosclerosis	0.000134	0.00091	CbGpPWpGaD
Nizatidine—HRH2—GPCR downstream signaling—CCL5—atherosclerosis	0.000133	0.000903	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—APOA4—atherosclerosis	0.000132	0.0009	CbGpPWpGaD
Nizatidine—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—atherosclerosis	0.000131	0.000891	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—CYP7A1—atherosclerosis	0.00013	0.000884	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—CNR2—atherosclerosis	0.000128	0.000871	CbGpPWpGaD
Nizatidine—HRH2—GPCR ligand binding—CXCL8—atherosclerosis	0.000128	0.000871	CbGpPWpGaD
Nizatidine—HRH2—Signaling by GPCR—MMP3—atherosclerosis	0.000128	0.000869	CbGpPWpGaD
Nizatidine—ABCB1—Allograft Rejection—VEGFA—atherosclerosis	0.000126	0.000862	CbGpPWpGaD
Nizatidine—HRH2—GPCR downstream signaling—PRKCG—atherosclerosis	0.000126	0.000859	CbGpPWpGaD
Nizatidine—BCHE—Metabolism of proteins—PLAUR—atherosclerosis	0.000124	0.000843	CbGpPWpGaD
Nizatidine—BCHE—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	0.000124	0.000843	CbGpPWpGaD
Nizatidine—ABCB1—Transmembrane transport of small molecules—TRPV1—atherosclerosis	0.000122	0.000828	CbGpPWpGaD
Nizatidine—HRH2—Signaling by GPCR—EDN1—atherosclerosis	0.000121	0.000827	CbGpPWpGaD
Nizatidine—BCHE—Metabolism of proteins—PLG—atherosclerosis	0.000121	0.000824	CbGpPWpGaD
Nizatidine—HRH2—Signaling by GPCR—CCL5—atherosclerosis	0.00012	0.00082	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—CYP27A1—atherosclerosis	0.00012	0.000817	CbGpPWpGaD
Nizatidine—BCHE—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	0.000118	0.000805	CbGpPWpGaD
Nizatidine—ABCB1—Transmembrane transport of small molecules—ABCG5—atherosclerosis	0.000117	0.000797	CbGpPWpGaD
Nizatidine—ABCB1—Allograft Rejection—TGFB1—atherosclerosis	0.000116	0.000791	CbGpPWpGaD
Nizatidine—BCHE—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	0.000115	0.000785	CbGpPWpGaD
Nizatidine—HRH2—Signaling by GPCR—PRKCG—atherosclerosis	0.000114	0.00078	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—VWF—atherosclerosis	0.000114	0.000777	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—ALOX15—atherosclerosis	0.000114	0.000775	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—ALOX5AP—atherosclerosis	0.000114	0.000775	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—APOA2—atherosclerosis	0.000114	0.000775	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—PLA2G2A—atherosclerosis	0.000114	0.000775	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—APOC3—atherosclerosis	0.000113	0.000772	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—LDLR—atherosclerosis	0.000113	0.000767	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—ABCG5—atherosclerosis	0.000112	0.000765	CbGpPWpGaD
Nizatidine—BCHE—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	0.000112	0.000765	CbGpPWpGaD
Nizatidine—HRH2—GPCR downstream signaling—AGT—atherosclerosis	0.000111	0.000756	CbGpPWpGaD
Nizatidine—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—atherosclerosis	0.00011	0.000753	CbGpPWpGaD
Nizatidine—BCHE—Metabolism of proteins—IGF2—atherosclerosis	0.00011	0.00075	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—CCL3—atherosclerosis	0.00011	0.000749	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—LPA—atherosclerosis	0.000108	0.000739	CbGpPWpGaD
Nizatidine—ABCB1—Allograft Rejection—TNF—atherosclerosis	0.000108	0.000739	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—LDLRAP1—atherosclerosis	0.000108	0.000739	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—NCF1—atherosclerosis	0.000105	0.000717	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—BGN—atherosclerosis	0.000105	0.000716	CbGpPWpGaD
Nizatidine—BCHE—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	0.000104	0.000711	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—APOA5—atherosclerosis	0.000104	0.000709	CbGpPWpGaD
Nizatidine—HRH2—GPCR downstream signaling—F2—atherosclerosis	0.000102	0.000698	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—PLTP—atherosclerosis	0.000102	0.000694	CbGpPWpGaD
Nizatidine—BCHE—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	0.000101	0.000688	CbGpPWpGaD
Nizatidine—HRH2—Signaling by GPCR—AGT—atherosclerosis	0.000101	0.000686	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—PLA2G1B—atherosclerosis	0.0001	0.000682	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—EDNRA—atherosclerosis	9.94e-05	0.000678	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—CCR2—atherosclerosis	9.94e-05	0.000678	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—CYBA—atherosclerosis	9.9e-05	0.000675	CbGpPWpGaD
Nizatidine—BCHE—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	9.9e-05	0.000675	CbGpPWpGaD
Nizatidine—BCHE—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	9.81e-05	0.000668	CbGpPWpGaD
Nizatidine—HRH2—GPCR downstream signaling—PIK3CG—atherosclerosis	9.8e-05	0.000668	CbGpPWpGaD
Nizatidine—BCHE—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	9.78e-05	0.000667	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—PARP1—atherosclerosis	9.69e-05	0.00066	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—PLAT—atherosclerosis	9.69e-05	0.00066	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—GHRL—atherosclerosis	9.69e-05	0.00066	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—ALOX5—atherosclerosis	9.67e-05	0.000659	CbGpPWpGaD
Nizatidine—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—atherosclerosis	9.56e-05	0.000651	CbGpPWpGaD
Nizatidine—ABCB1—HIF-1-alpha transcription factor network—AKT1—atherosclerosis	9.32e-05	0.000635	CbGpPWpGaD
Nizatidine—HRH2—Signaling by GPCR—F2—atherosclerosis	9.3e-05	0.000634	CbGpPWpGaD
Nizatidine—BCHE—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	8.93e-05	0.000609	CbGpPWpGaD
Nizatidine—HRH2—Signaling by GPCR—PIK3CG—atherosclerosis	8.9e-05	0.000607	CbGpPWpGaD
Nizatidine—BCHE—Metabolism of proteins—MMP1—atherosclerosis	8.84e-05	0.000602	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—ABCG8—atherosclerosis	8.83e-05	0.000602	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—LTA4H—atherosclerosis	8.83e-05	0.000602	CbGpPWpGaD
Nizatidine—BCHE—Metabolism of proteins—AGT—atherosclerosis	8.73e-05	0.000595	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—NAMPT—atherosclerosis	8.67e-05	0.000591	CbGpPWpGaD
Nizatidine—ABCB1—Transmembrane transport of small molecules—CETP—atherosclerosis	8.66e-05	0.00059	CbGpPWpGaD
Nizatidine—BCHE—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	8.62e-05	0.000588	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—LIPC—atherosclerosis	8.62e-05	0.000587	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—APOC3—atherosclerosis	8.56e-05	0.000584	CbGpPWpGaD
Nizatidine—BCHE—Metabolism of proteins—LEP—atherosclerosis	8.55e-05	0.000583	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—LDLR—atherosclerosis	8.51e-05	0.00058	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—KNG1—atherosclerosis	8.5e-05	0.00058	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—AGTR1—atherosclerosis	8.45e-05	0.000576	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—CETP—atherosclerosis	8.31e-05	0.000567	CbGpPWpGaD
Nizatidine—HRH2—Signaling by GPCR—CCL2—atherosclerosis	8.29e-05	0.000565	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—PLG—atherosclerosis	8.24e-05	0.000561	CbGpPWpGaD
Nizatidine—BCHE—Metabolism of proteins—F2—atherosclerosis	8.06e-05	0.00055	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—SCARB1—atherosclerosis	7.96e-05	0.000543	CbGpPWpGaD
Nizatidine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—atherosclerosis	7.92e-05	0.00054	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—SOCS3—atherosclerosis	7.8e-05	0.000532	CbGpPWpGaD
Nizatidine—BCHE—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	7.75e-05	0.000528	CbGpPWpGaD
Nizatidine—ABCB1—Transmembrane transport of small molecules—PLAT—atherosclerosis	7.63e-05	0.00052	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—MMP3—atherosclerosis	7.53e-05	0.000514	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—HMGCR—atherosclerosis	7.52e-05	0.000512	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—IGF2—atherosclerosis	7.5e-05	0.000511	CbGpPWpGaD
Nizatidine—BCHE—Metabolism of proteins—INS—atherosclerosis	7.31e-05	0.000498	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—APOB—atherosclerosis	7.28e-05	0.000496	CbGpPWpGaD
Nizatidine—HRH2—GPCR downstream signaling—CXCL8—atherosclerosis	7.22e-05	0.000492	CbGpPWpGaD
Nizatidine—BCHE—Metabolism of proteins—CCL2—atherosclerosis	7.19e-05	0.00049	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—EDN1—atherosclerosis	7.17e-05	0.000488	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—CCL5—atherosclerosis	7.11e-05	0.000485	CbGpPWpGaD
Nizatidine—BCHE—Metabolism of proteins—IGF1—atherosclerosis	7.07e-05	0.000482	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—ABCG1—atherosclerosis	6.98e-05	0.000476	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—LPL—atherosclerosis	6.95e-05	0.000474	CbGpPWpGaD
Nizatidine—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—atherosclerosis	6.88e-05	0.000469	CbGpPWpGaD
Nizatidine—BCHE—Metabolism of proteins—MMP2—atherosclerosis	6.84e-05	0.000466	CbGpPWpGaD
Nizatidine—BCHE—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	6.78e-05	0.000462	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—PRKCG—atherosclerosis	6.76e-05	0.000461	CbGpPWpGaD
Nizatidine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—atherosclerosis	6.76e-05	0.000461	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—ABCA1—atherosclerosis	6.7e-05	0.000457	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—SPP1—atherosclerosis	6.59e-05	0.000449	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—LCAT—atherosclerosis	6.57e-05	0.000448	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—FABP4—atherosclerosis	6.57e-05	0.000448	CbGpPWpGaD
Nizatidine—HRH2—Signaling by GPCR—CXCL8—atherosclerosis	6.56e-05	0.000447	CbGpPWpGaD
Nizatidine—ABCB1—Transmembrane transport of small molecules—PLG—atherosclerosis	6.49e-05	0.000442	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—APOA4—atherosclerosis	6.44e-05	0.000439	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—CYP7A1—atherosclerosis	6.33e-05	0.000432	CbGpPWpGaD
Nizatidine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—atherosclerosis	6.24e-05	0.000425	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—PDGFB—atherosclerosis	6.09e-05	0.000415	CbGpPWpGaD
Nizatidine—ABCB1—Transmembrane transport of small molecules—HMOX1—atherosclerosis	5.99e-05	0.000408	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—AGT—atherosclerosis	5.95e-05	0.000405	CbGpPWpGaD
Nizatidine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—atherosclerosis	5.9e-05	0.000402	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—CYP27A1—atherosclerosis	5.85e-05	0.000399	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—LEP—atherosclerosis	5.83e-05	0.000397	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—APOE—atherosclerosis	5.83e-05	0.000397	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—CAV1—atherosclerosis	5.77e-05	0.000394	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—APOA1—atherosclerosis	5.76e-05	0.000393	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—HMOX1—atherosclerosis	5.75e-05	0.000392	CbGpPWpGaD
Nizatidine—ABCB1—Transmembrane transport of small molecules—APOB—atherosclerosis	5.74e-05	0.000391	CbGpPWpGaD
Nizatidine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—atherosclerosis	5.73e-05	0.00039	CbGpPWpGaD
Nizatidine—BCHE—Metabolism of proteins—CXCL8—atherosclerosis	5.68e-05	0.000387	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—ESR1—atherosclerosis	5.56e-05	0.000379	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—ALOX15—atherosclerosis	5.55e-05	0.000378	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—ALOX5AP—atherosclerosis	5.55e-05	0.000378	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—PLA2G2A—atherosclerosis	5.55e-05	0.000378	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—APOA2—atherosclerosis	5.55e-05	0.000378	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—APOB—atherosclerosis	5.51e-05	0.000375	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—F2—atherosclerosis	5.5e-05	0.000375	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—ABCG5—atherosclerosis	5.48e-05	0.000373	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—GSTM1—atherosclerosis	5.36e-05	0.000365	CbGpPWpGaD
Nizatidine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—atherosclerosis	5.35e-05	0.000365	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—LPA—atherosclerosis	5.29e-05	0.000361	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—PIK3CG—atherosclerosis	5.26e-05	0.000358	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—LPL—atherosclerosis	5.26e-05	0.000358	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—GPX1—atherosclerosis	5.13e-05	0.00035	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—BGN—atherosclerosis	5.13e-05	0.000349	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—APOA5—atherosclerosis	5.07e-05	0.000346	CbGpPWpGaD
Nizatidine—HRH2—Signaling by GPCR—MAPK3—atherosclerosis	5.04e-05	0.000343	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—CD36—atherosclerosis	5e-05	0.000341	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—INS—atherosclerosis	4.98e-05	0.000339	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—CCL2—atherosclerosis	4.9e-05	0.000334	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—PLA2G1B—atherosclerosis	4.88e-05	0.000333	CbGpPWpGaD
Nizatidine—ABCB1—Transmembrane transport of small molecules—PPARA—atherosclerosis	4.84e-05	0.00033	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—IGF1—atherosclerosis	4.82e-05	0.000328	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—MTHFR—atherosclerosis	4.73e-05	0.000323	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—ALOX5—atherosclerosis	4.72e-05	0.000322	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—PPARA—atherosclerosis	4.64e-05	0.000317	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—SERPINE1—atherosclerosis	4.57e-05	0.000312	CbGpPWpGaD
Nizatidine—ABCB1—Transmembrane transport of small molecules—APOA1—atherosclerosis	4.54e-05	0.000309	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—AGT—atherosclerosis	4.5e-05	0.000307	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—APOE—atherosclerosis	4.41e-05	0.0003	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—CAV1—atherosclerosis	4.37e-05	0.000298	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—NOS3—atherosclerosis	4.37e-05	0.000298	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—APOA1—atherosclerosis	4.36e-05	0.000297	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—NAMPT—atherosclerosis	4.23e-05	0.000288	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—LIPC—atherosclerosis	4.2e-05	0.000287	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—APOC3—atherosclerosis	4.18e-05	0.000285	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—LDLR—atherosclerosis	4.15e-05	0.000283	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—CETP—atherosclerosis	4.06e-05	0.000276	CbGpPWpGaD
Nizatidine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	3.98e-05	0.000271	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—PIK3CG—atherosclerosis	3.98e-05	0.000271	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—SCARB1—atherosclerosis	3.88e-05	0.000265	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—CXCL8—atherosclerosis	3.87e-05	0.000264	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—PPARG—atherosclerosis	3.84e-05	0.000262	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—INS—atherosclerosis	3.77e-05	0.000257	CbGpPWpGaD
Nizatidine—HRH2—GPCR downstream signaling—AKT1—atherosclerosis	3.74e-05	0.000255	CbGpPWpGaD
Nizatidine—HRH2—Signaling by GPCR—IL6—atherosclerosis	3.68e-05	0.000251	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—HMGCR—atherosclerosis	3.67e-05	0.00025	CbGpPWpGaD
Nizatidine—ABCB1—Transmembrane transport of small molecules—ALB—atherosclerosis	3.6e-05	0.000245	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—MMP9—atherosclerosis	3.5e-05	0.000239	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—NFKB1—atherosclerosis	3.47e-05	0.000236	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—ALB—atherosclerosis	3.45e-05	0.000235	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—MAPK8—atherosclerosis	3.41e-05	0.000232	CbGpPWpGaD
Nizatidine—HRH2—Signaling by GPCR—AKT1—atherosclerosis	3.4e-05	0.000232	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—NOS3—atherosclerosis	3.3e-05	0.000225	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—ABCA1—atherosclerosis	3.27e-05	0.000223	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—VEGFA—atherosclerosis	3.15e-05	0.000214	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—STAT3—atherosclerosis	3.11e-05	0.000212	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—PTGS2—atherosclerosis	3.02e-05	0.000206	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—MAPK3—atherosclerosis	2.98e-05	0.000203	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—TGFB1—atherosclerosis	2.89e-05	0.000197	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—HMOX1—atherosclerosis	2.81e-05	0.000191	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—APOB—atherosclerosis	2.69e-05	0.000183	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—GSTM1—atherosclerosis	2.61e-05	0.000178	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—LPL—atherosclerosis	2.57e-05	0.000175	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—GPX1—atherosclerosis	2.5e-05	0.000171	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—CD36—atherosclerosis	2.44e-05	0.000166	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—MTHFR—atherosclerosis	2.31e-05	0.000157	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—PPARA—atherosclerosis	2.27e-05	0.000154	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—AGT—atherosclerosis	2.19e-05	0.00015	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—IL6—atherosclerosis	2.18e-05	0.000148	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—APOE—atherosclerosis	2.15e-05	0.000147	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—CAV1—atherosclerosis	2.13e-05	0.000145	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—APOA1—atherosclerosis	2.13e-05	0.000145	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—AKT1—atherosclerosis	2.01e-05	0.000137	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—PIK3CG—atherosclerosis	1.94e-05	0.000132	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—PPARG—atherosclerosis	1.87e-05	0.000128	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—INS—atherosclerosis	1.84e-05	0.000125	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—ALB—atherosclerosis	1.68e-05	0.000115	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—NOS3—atherosclerosis	1.61e-05	0.00011	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—AKT1—atherosclerosis	1.52e-05	0.000103	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—PTGS2—atherosclerosis	1.47e-05	0.0001	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—AKT1—atherosclerosis	7.41e-06	5.05e-05	CbGpPWpGaD
